Interaction of glutathione‐s‐transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome. (25th February 2020)

• Record Type: Journal Article
• Authors: Katiyar, Tridiv; Yadav, Vinay; Maurya, Shailendra S.; Ruwali, Munindra; Singh, Madhu; Hasan, Feza; Pandey, Rahul; Mehrotra, Divya; Singh, Sudhir; Mishra, Shambhavi; Hadi, Rahat; Bhatt, Madan L. B.; Parmar, Devendra
• Is Part Of: Environmental and molecular mutagenesis. Volume 61:Number 5(2020)
• Page Start: 574
• Page End: 584
• Publication Date: 2020-02-25
• Subjects: GSTs -- HNSCC -- interaction -- polymorphism -- risk -- tobacco; Mutagenesis -- Periodicals; Molecular genetics -- Periodicals; Mutagenèse -- Périodiques; Mutagenèse chimique -- Périodiques; Mutation -- Périodiques; Maladies de l'environnement -- Périodiques; Génétique moléculaire -- Périodiques; 576.542
• DOI: 10.1002/em.22362
• Languages: English
• ISSNs: 0893-6692

Abstract

Abstract: The present case‐control study aimed to investigate the role of interaction of glutathione‐s‐transferase (GST) genotypes with environmental risk factors in determining susceptibility to head and neck squamous cell carcinoma (HNSCC) involving 1, 250 cases and equal number of healthy controls. An increase in the risk of HNSCC and its subsites (larynx, pharynx, and oral cavity) was observed among the cases with null genotypes of GSTM1 (odds ratio [OR] = 1.87) or GSTT1 (OR = 1.39) while reduced risk (OR = 0.81) was observed the cases with variant genotype of GSTP1. Tobacco use in the form of smoking or chewing interacted multiplicatively with GSTM1 or GSTT1 to increase the risk several folds (3–10 folds) in HNSCC and its subsites. Alcohol use also increased the risk (2–3 folds) to HNSCC and its subsites in cases with null or variant genotypes of GSTs, though this risk was of lesser magnitude when compared to the tobacco users. A synergistic effect of both, tobacco smoking and alcohol drinking, led to several folds (25‐folds) increased risk to HNSCC among the cases with null genotype of GSTM1 and GSTT1 when compared to nonsmokers and nondrinkers with wild genotype of GSTM1 and GSTT1 in controls. Furthermore, cases with variant genotypes of GSTP1 (Val/Val) showed superior treatment response with improved survival rate and lower risk of death when compared to the patients with wild type genotype (Ile/Ile). The data suggest that though polymorphism in GSTs may be a modest risk factor for determining HNSCC risk, gene‐environment interactions significantly modify the susceptibility to HNSCC by several folds.